Investigation of N-desmethyl-acetamiprid-induced neurotransmitter disturbances in cerebrospinal fluid from leukemia patients
- PMID: 41173078
- DOI: 10.1016/j.etap.2025.104858
Investigation of N-desmethyl-acetamiprid-induced neurotransmitter disturbances in cerebrospinal fluid from leukemia patients
Abstract
Neonicotinoids (NEOs) and their metabolites impact neuronal function; however, their effects on neurotransmitters remain unexplored. We analyzed cerebrospinal fluid (CSF) from leukemia patients with differing concentrations of N-desmethyl-acetamiprid (N-dm-ACE) for neurotransmitter profiling. Neurotransmitters and biomarkers were measured in CSF, blood, and serum from 39 patients (19 low and 20 high N-dm-ACE) across three age groups: children, adults, and elders. Significant differences (p ≤ 0.05) in neurotransmitters were found among groups, including glutamic acid (253.45 ± 388.16 & 101.11 ± 52.79), aspartic acid (79.64 ± 87.46 & 0.00), tryptophan (325.89 ± 76.47 & 508.09 ± 331.35), and tyrosine (984.41 ± 348.78 ng/mL). Regression analysis indicated that N-dm-ACE is significantly (p < 0.05) positively associated with serum total proteins and negatively with betaine-aldehyde-chloride and ornithine. This suggests that increased accumulation of N-dm-ACE in the CNS may elevate the risk of neurological or neurotoxic conditions. Further studies are needed to better understand the intricate relationship between NEOs, particularly N-dm-ACE, and brain health.
Keywords: Cerebrospinal fluid; Leukemia; Neonicotinoids; Neurological disorders; Neurotoxicity.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest We Authors of this paper declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
LinkOut - more resources
Full Text Sources
Miscellaneous
